Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up
Conditions: Schizophrenia; Psychotic Disorders; Psychosis Interventions: Drug: Aripiprazole; Drug: Risperidone Sponsors: Fundación Marques de Valdecilla; Centro de Investigación Biomédica en Red de Salud Mental; Instituto de Investigación Marqués de Valdecilla Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials